학술논문

Melanoma and Human Leukocyte Antigen (HLA): Immunogenicity of 69 HLA Class I Alleles With 11 Antigens Expressed in Melanoma Tumors.
Document Type
Article
Source
Cancer Informatics. 5/22/2023, p1-13. 13p.
Subject
*HLA histocompatibility antigens
*HISTOCOMPATIBILITY class I antigens
*IMMUNE response
*PROGRAMMED cell death 1 receptors
*T cells
*ANTIGENS
*T cell receptors
*MELANOMA
Language
ISSN
1176-9351
Abstract
Host immunogenetics play a critical role in the human immune response to melanoma, influencing both melanoma prevalence and immunotherapy outcomes. Beneficial outcomes that stimulate T cell response hinge on binding affinity and immunogenicity of human leukocyte antigen (HLA) with melanoma antigen epitopes. Here, we use an in silico approach to characterize binding affinity and immunogenicity of 69 HLA Class I human leukocyte antigen alleles to epitopes of 11 known melanoma antigens. The findings document a significant proportion of positively immunogenic epitope-allele combinations, with the highest proportions of positive immunogenicity found for the Q13072/BAGE1 melanoma antigen and alleles of the HLA B and C genes. The findings are discussed in terms of a personalized precision HLA-mediated adjunct to immune checkpoint blockade immunotherapy to maximize tumor elimination. [ABSTRACT FROM AUTHOR]